Tag #Vaccine Production

What is the impact of the $45 million funding on vaccine production and access in Africa?

VaxSen, the Institut Pasteur de Dakar's vaccine production and commercialization entity, received $45 million in funding from the US Development Finance Corporation (DFC), the African Development Bank (AfDB), and the International Finance Corporation (IFC). This will expand vaccine production capacity at their new Madiba facility, boosting Senegal's economy and addressing global vaccine shortages. The funding includes a $15 million loan and a previous $3 million grant from the DFC.